The global sales of phlebotomy Equipment are estimated to be worth USD 14,693.1 million in 2025 and anticipated to reach a value of USD 21,468.1 million by 2035. Sales are projected to rise at a CAGR of 3.9% over the forecast period between 2025 and 2035. The revenue generated by phlebotomy Equipment in 2024 was USD 14,044.3 million.
This increasing prevalence of blood disorders is becoming the prominent reason in the growth of the market for phlebotomy equipment, as such conditions call for frequent diagnostic testing and monitoring. Blood disorders like anemia, hemophilia, leukemia, and thrombocytopenia have a global prevalence in millions, and regular blood sampling is required for diagnosis, treatment planning, and management.
Secondary to these chronic diseases, with increased incidence of diabetes, as well as cardiovascular disorders, are the rising rates in cases of secondary blood abnormality, thus raising demands for phlebotomy procedures. In addition to that, the growing prevalence of cancers worldwide have led to increased cases of chemotherapy-associated complications, such as leukopenia and anemia, thus further amplifying the need for blood collection and analysis where phlebotomy Equipment are required.
Global Phlebotomy Equipment Industry Assessment
| Attributes | Key Insights |
|---|---|
| Historical Size, 2024 | USD 14,044.3 million |
| Estimated Size, 2025 | USD 14,693.1 million |
| Projected Size, 2035 | USD 21,468.1 million |
| Value-based CAGR (2025 to 2035) | 3.9% |
In addition to disease prevalence, advancements in diagnostic techniques and the growing adoption of personalized medicine have heightened the reliance on blood tests for early diagnosis and medical treatments. This surge in diagnostic and therapeutic applications contributes to the robust demand for advanced phlebotomy equipment, including needles, blood collection tubes, and lancets.
Anemia represents the most common type of noncancerous blood disorder. The United States. Centers for Disease Control and Prevention estimates that about 3 million people in the United States have some type of anemia. Anemia is the result of not having enough healthy red blood cells. As many as 900,000 Americans experience a blood clot (venous thrombosis) each year and about 100,000 people die from the condition.
As per the Centers for Disease Control and Prevention, sickle cell disease, an inherited disorder, affects about 100,000 Americans and is more common in Black Americans. About 1 out of every 365 Black newborns have the disease and 1 in 13 have the sickle cell trait.
As these disorders become more prevalent due to factors such as aging populations, lifestyle changes, and improved diagnostic capabilities, there is a corresponding increase in the need for phlebotomy equipment in treatment and diagnostics. Hence, because of this reason the need for phlebotomy Equipment is increasing in medical settings.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The below table presents the expected CAGR for the global phlebotomy Equipment market over several semi-annual periods spanning from 2025 to 2035. In the first half (H1) of the decade from 2024 to 2035, the business is predicted to surge at a CAGR of 4.6%, followed by a slightly lower growth rate of 4.3% in the second half (H2) of the same decade.
| Particular | Value CAGR |
|---|---|
| H1 | 4.6% (2024 to 2034) |
| H2 | 4.3% (2024 to 2034) |
| H1 | 3.9% (2025 to 2035) |
| H2 | 3.4% (2025 to 2035) |
Moving into the subsequent period, from H1 2025 to H2 2035, the CAGR is projected to decrease slightly to 3.9% in the first half and decrease moderately at 3.4% in the second half. In the first half (H1) the market witnessed a decrease of 70.00 BPS while in the second half (H2), the market witnessed an increase of 90.00 BPS.
Increasing Applications for Collection, Testing and Blood Storage Is Increasing Adoption of Phlebotomy Equipment.
Phlebotomy equipment is important in acquiring samples for diagnostic testing. This diagnostic testing is for diagnosing a variety of medical conditions, such as infections, blood disorders, and chronic diseases. With an increase in these conditions, there is an increase in the demand for diagnostic testing.
According to America's Blood Centers statistics 2022, blood centers in the United States provided 10,879,000 RBCs to hospitals in 2019. United States. blood centers also provided 2,508,000 units of platelets (both apheresis and whole blood derived) to hospitals in 2019. Blood centers in the United States. provided hospitals with 2,679,000 units of plasma in 2019. These statistics indicate the extensive use of phlebotomy equipment.
Blood storage is an important process in the blood banking industry, where phlebotomy equipment is used, because it helps in maintaining the quality of blood and its medical effectiveness. Blood products' storage in a blood bank is crucial for the blood banks since it enables them to establish a stable supply of safe blood that can be stored for long periods without losing effectiveness.
Health care service providers need phlebotomy equipment to get blood samples with a high level of safety and effectiveness, thereby assuring diagnosis, proper treatment, and good research output. Blood collection equipment plays a core role in the critical healthcare process that necessitates continuous demand and growth in the market.
Increasing Awareness about blood safety is favoring the Growth for Phlebotomy Equipment Market
Blood collection has faced growing concerns about healthcare-associated infections, bloodborne pathogens, and needlestick injuries, and the necessity to increase safety for the patient and the healthcare provider has gained importance. It becomes essential that phlebotomy equipment promote blood safety and incorporate safety-engineered needles and needleless blood collection systems.
It is a procedure for keeping safe and effective practices about the collection, storage, and usage of the donated blood. Collected together, they are termed as haemovigilance and encompass the entire chain of the transfusion process. It standardizes the use of blood in the healthcare sector.
The WHO Global Database on Blood Safety (GDBS) was established in 1998 with the objective to collect and analyze data from all countries on blood and blood product safety as the basis for effective action to improve blood safety and availability globally. The starting point of a safe blood supply is a stable population of regular voluntary non-remunerated blood donors.
According to World Health Organization - Global Status Report On Blood Safety and Availability (2021), It is estimated that 118.5 million blood donations were made in the 171 countries during the reporting period. 40% of these are collected in high-income countries, home to 16% of the world’s population.
Conclusion Rising awareness on blood safety is a must for the prevention of the infectious diseases being transmitted, maintaining patient and healthcare worker's safety, promotion of public health, maintenance of healthcare systems, and observance of legal and ethical standards in healthcare practice.
Increasing Demand for Diagnostic Testing a Significant Market Opportunity for Phlebotomy Equipment
The need for diagnostic testing is increasing with patient numbers at an all-time high and healthcare services at capacity. However, simple and safe solutions, along with digitized or consolidated services, will improve clinical scenarios and allow for quicker and more equitable access to health care.
Demand for diagnostic testing continues to rise due to converging factors. Non-communicable diseases are widespread; According to National Association of Chronic Disease Directors (2022), Nearly 60% of adult Americans have at least one chronic disease. Chronic conditions like diabetes, cancer, and cardiovascular disease are the leading causes of death in the United States.
Further increased preventive healthcare and early diagnosis to improve health outcomes by decreasing healthcare costs. Some programs include screening, well-health check-ups, as well as wellness initiatives urging patients to undergo routine diagnostics tests for early detection and recognition of health conditions, all with increasing demand for medical devices that are used in a screening and preventive healthcare framework.
Advanced and safety-enhanced phlebotomy equipment is becoming the need of the hour to improve patient outcomes and avoid diagnostic errors. Therefore, the rising demand in the market has opened new doors for innovation and portfolio expansion among the market players to meet the growing needs of diagnostic laboratories.
Lack of Skilled Professionals Is Emerging as Significant Growth Barrier for Phlebotomy Equipment Market.
This involves highly trained and skilled medical workers to operate. Since only a few individuals can properly operate the devices used for blood collection and sample handling, the usage of equipment in phlebotomy is limited due to shortages of skilled phlebotomists or healthcare workers who can employ the techniques in blood collection.
Medical errors, majorly caused due to unskilled workers, are the third-leading cause of death after heart disease and cancer. The US Food and Drug Administration receives over 100,000 reports of medication errors each year. 41% of US citizens have claimed to be the sufferer of a medical error.
According to the United States. Bureau of Labor Statistics (BLS) 2021, employer demand for phlebotomists is projected to increase by 17% between 2019 and 2029
Overall, the absence of skilled professionals in phlebotomy presents a major restraint in the market for phlebotomy equipment because of its implications on training cost and time, quality, and accuracy concerns, and the possibility of adverse events. Addressing this skills gap will therefore be fundamental to the realization of phlebotomy equipment's potential in the health care sector.
Principal Consultant
The global phlebotomy Equipment industry recorded a CAGR of 3.0% during the historical period between 2020 and 2024. The growth of phlebotomy Equipment industry was positive as it reached a value of USD 14,044.3 million in 2024 from USD 12,299.50 million in 2020.
The phlebotomy equipment market has experienced significant change, influenced by the rising demand for efficient blood collection techniques and developments in healthcare infrastructure. Increasing patient safety and comfort concerns have resulted in the development of minimally invasive and ergonomically designed equipment, such as butterfly needles, safety syringes, and vacuum blood collection tubes. Technological advancements have led to automated blood collection systems and devices integrated with barcode technology to enhance accuracy and workflow efficiency.
Wearing and point-of-care devices have been increasingly adopted and transform traditional phlebotomy practices, allowing remote and real-time blood sampling. Vein visualization technology and digital diagnostic tools also advance success rates and make less painful for patients.
Sustainable material and single use for environmental issues is also being made a priority by manufacturers, along with the changing demands in the healthcare sector have brought about phlebotomy equipment as an unavoidable aspect of modern medical diagnosis.
Tier 1 companies comprise market leaders with a significant market share of 26.1% in global market. These companies engage in strategic partnerships and acquisitions to expand their product portfolios and access cutting-edge technologies.
Additionally, they emphasize extensive clinical trials to validate the efficacy and safety of their products. Prominent companies in tier 1 include Cardinal Health, Source-Ray, Inc., Becton, Dickinson and Company, Terumo Medical Corporation and Medline Industries, Inc.
Tier 2 companies include mid-size players with revenue of USD 50 to 100 million having presence in specific regions and highly influencing the local market and holds around 33.5% market share. They typically pursue partnerships with academic institutions and research organizations to leverage emerging technologies and expedite product development.
These companies often emphasize agility and adaptability, allowing them to quickly bring new treatments to market, additionally targeting specific types medical conditions. Additionally, they focus on cost-effective production methods to offer competitive pricing. Prominent companies in tier 2 include F.L. Medical, Timedico A/S, Heathrow Scientific LLC and JAC Medical Products Inc.
Finally, Tier 3 companies, such as LI Marketlab, Inc., UMF Medical, Hill Laboratories Company and Clinton Industries, Inc. They specialize in specific products and cater to niche markets, adding diversity to the industry.
Overall, while Tier 1 companies are the primary drivers of the market, Tier 2 and 3 companies also make significant contributions, ensuring the phlebotomy Equipment sales remains dynamic and competitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section below covers the industry analysis for the phlebotomy Equipment market for different countries. Market demand analysis on key countries in several regions of the globe, including North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle Ease & Africa, is provided.
The United States is anticipated to remain at the forefront in North America, with higher market share through 2035. In South Asia & Pacific, India is projected to witness a CAGR of 4.0% by 2035.
| Countries | Value CAGR (2025 to 2035) |
|---|---|
| United States | 4.0% |
| Germany | 5.1% |
| China | 5.8% |
| France | 5.5% |
| India | 6.3% |
| Spain | 4.9% |
| Australia & New Zealand | 5.2% |
| South Korea | 5.9% |
United States. phlebotomy Equipment market is poised to exhibit a CAGR of 4.0% between 2025 and 2035. Currently, it holds the highest share in the North American market.
The United States dominates the phlebotomy Equipment market because of its strong research and development ecosystem in life sciences, biotechnology, and pharmaceuticals. It has a huge number of academic institutions, research organizations, and private companies driving continuous innovation in molecular biology and protein analysis. Advanced phlebotomy Equipment techniques come as an example of these, where US-based researchers and biotech companies pioneer more efficient.
Collaborative R&D projects between medical device companies and academic institutions are accelerating the development of next-generation solutions, including minimally invasive and wearable blood sampling devices. Additionally, significant investments in material science research aim to produce eco-friendly and single-use products that meet regulatory and environmental standards.
This dedicated focus on R&D ensures the continuous evolution of phlebotomy technologies, addressing emerging healthcare needs and driving the availability of cutting-edge products in the United States market.
China’s phlebotomy Equipment market is poised to exhibit a CAGR of 5.8% between 2025 and 2035. Currently, it holds the highest share in the East Asia market, and the trend is expected to continue during the forecast period.
China has established itself as a global hub for medical device production, leveraging cost-effective manufacturing processes, advanced infrastructure, and skilled labor. These factors allow it to produce quality phlebotomy equipment at inexpensive rates for the local population while maintaining competitive prices for markets overseas.
Furthermore, its efforts on technological innovation coupled with government support for the healthcare industry have further enhanced the innovation of advanced blood collection devices. The Chinese manufacturers are increasingly placing a focus on automation and safety features along with product precision to meet global standards. The increasing healthcare infrastructure as well as the population in China add to the demand in the phlebotomy equipment market, which ensures it is at the top of this market.
India’s phlebotomy Equipment market is poised to exhibit a CAGR of 6.3% between 2025 and 2035. Currently, it holds the highest share in the South Asia & Pacific market, and the trend is expected to continue during the forecast period.
Lifestyle changes, aging demographics, and urbanization have increased the prevalence of diabetes, cardiovascular diseases, cancer, and kidney disorders. These diseases require regular blood tests for diagnosis, monitoring, and treatment, hence creating a consistent demand for advanced and reliable phlebotomy equipment.
The increasing demand is being addressed by the growing healthcare infrastructure in India through more diagnostic capabilities, especially in urban and semi-urban areas. The expanding network of hospitals, diagnostic labs, and blood banks is adopting modern blood collection devices to improve accuracy and patient comfort.
Moreover, increased health awareness and routine screening programs have further accelerated blood testing volumes, establishing chronic disease prevalence as a significant driver for market growth in India.
The section contains information about the leading segments in the industry. By product, the phlebotomy supplies segment holds the highest market share of 70.4% in 2025.
| By Product | Phlebotomy Supplies |
|---|---|
| Value Share (2025) | 70.4% |
Phlebotomy supplies dominate the phlebotomy equipment market due to their essential role in every blood collection procedure and their high consumption rate. Products such as needles, syringes, tourniquets, blood collection tubes, and alcohol swabs are single-use items, ensuring sterility and reducing the risk of cross-contamination. This high turnover creates consistent demand, especially in settings like hospitals, diagnostic labs, and blood donation centers.
The affordability and availability of these supplies further contribute to their dominance, as they are integral to both manual and automated blood collection processes. Moreover, advancements in safety-engineered supplies, such as needles with safety shields and vacuum-based collection systems, have boosted their adoption by addressing patient and healthcare worker safety concerns. With the increasing volume of diagnostic procedures globally, phlebotomy supplies remain indispensable, securing their leading position in the market.
| By End User | Hospitals |
|---|---|
| Value Share (2025) | 24.9% |
By end user, the hospitals segment holds the highest market share of 24.9% in 2025.
Blood collection is a common practice in hospitals for diagnosing various conditions, monitoring treatments, and conducting pre-operative assessments. The patient population in a hospital varies from emergency cases to chronic disease management, which calls for a continuous demand for phlebotomy equipment.
Moreover, hospitals have better diagnostic facilities and deal with critical cases that involve frequent and accurate blood sampling. The availability of professional healthcare workers ensures the utilization of modern phlebotomy technologies, including automated blood collection systems and vein visualization devices. With the increasing concern for patient safety and infection control, hospitals are using high-quality, safety-engineered phlebotomy products, making them the largest end-user segment in the market.
The market players are using strategies to stay competitive, such as product differentiation through innovative formulations, strategic partnerships with healthcare providers for distribution. Another key strategic focus of these companies is to actively look for strategic partners to bolster their product portfolios and expand their global market presence.
Recent Industry Developments in Phlebotomy Equipment Market
In terms of product, the industry is divided into- Phlebotomy supplies, phlebotomy carts, phlebotomy cabinets and phlebotomy chairs and phlebotomy tables.
In terms of usage, the industry is segregated into- disposable devices and reusable devices.
In terms of end user, the industry is segregated into- Hospitals, ambulatory surgical centers, diagnostic laboratories, skilled nursing facilities, long term care centers, specialty clinics, blood banks and home healthcare providers and others.
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
The global phlebotomy Equipment market is projected to witness CAGR of 3.9% between 2025 and 2035.
The global phlebotomy Equipment industry stood at USD 14,044.3 million in 2024.
The global phlebotomy Equipment market is anticipated to reach USD 21,468.1 million by 2035 end.
India is set to record the highest CAGR of 6.3% in the assessment period.
The key players operating in the global phlebotomy Equipment market include Cardinal Health, Source-Ray, Inc., Becton, Dickinson and Company, Terumo Medical Corporation, SARSTEDT AG & Co. KG, Medline Industries, Inc., Vitrex Medical A/S, F.L. Medical, Timedico A/S, Heathrow Scientific LLC and JAC Medical Products Inc.
Explore Healthcare Insights
View Reports
Phlebotomy Equipment Market
